Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

teva_copy

Impax to acquire Teva, Allergan generic drugs for $586 million

June 22, 2016 Research and Development, Sales and Marketing Allergan, Impax, Teva, generics

Impax Laboratories (NASDAQ: IPXL) has announced that it has entered into agreements with Teva and affiliates of Allergan to acquire …
News

Murdo Gordon gets Chief Commercial Officer role at Bristol-Myers Squibb

June 21, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, chief commercial officer

Bristol-Myers Squibb (NYSE: BMY) has announced the appointment of Munro Gordon as executive vice president and chief commercial officer, effective …
Appointment
shutterstock_67313209

Doctors prescribe more brand drugs for free meals from pharma industry – Study

June 21, 2016 Manufacturing and Production, Research and Development, Sales and Marketing JAMA, regulation, research

Doctors who received free meals from the pharmaceutical representatives were more likely to prescribe the brand-name medication that was being …
News
esteban

Amgen appoints Esteban Santos as executive VP of operations

June 20, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amgen (NASDAQ: AMGN) has announced the appointment of Esteban Santos as executive vice president, operations. Santos will be responsible for …
Appointment
stocks1

Weekly Movers: Global Blood Therapeutics, Sophiris Bio…

June 20, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Global Blood Therapeutics, Shares, markets, pharma, stocks

Here’s a quick look at some of the biggest movers of the week:Sophiris Bio (Nasdaq: SPHS) stock rose to nearly …
Feature
pharma_pill_manufacturing

Valeant plots significant investment in Canadian operations

June 20, 2016 Manufacturing and Production, Sales and Marketing Canada, Valeant, manufacturing

Valeant Pharmaceuticals (NYSE: VRX) has announced that it plans to expand its Canadian operations with a $27.5 million expansion of …
News
nhs_sign

NHS looking to offer free healthcare apps, devices from next year

June 20, 2016 Medical Communications, Research and Development, Sales and Marketing DigitalHealth, HealthTech, NHS, NICE

The NHS will offer devices and apps for free to help patients manage their health, starting in UK next year.
News
gsk_boronia_australia

GSK triple combo COPD therapy shows superiority in Phase III trials

June 20, 2016 Research and Development, Sales and Marketing COPD, GSK, phase III

GlaxoSmithKline (LSE: GSK), along with Innoviva (NASDAQ: INVA), have presented positive top-line results from a pivotal Phase III trial for …
News

Chi-Med to get $10 million milestone from AstraZeneca after initiation of expanded Phase II trials in NSCLC

June 20, 2016 Research and Development, Sales and Marketing AstraZeneca, Chi-Med, Iressa, Tagrisso, drug trial, lung cancer

Hutchison China MediTech (Nasdaq: HCM) on Monday said it is expanding Phase II trials in non-small cell lung cancer to …
News
lab

Federal panel to review proposal for first human CRISPR test

June 20, 2016 Research and Development, Sales and Marketing crispr, gene editing, human testing, oncology

A US Federal safety board is set to review a proposal for the first human use of the gene editing …
News

Nice backs BMS’ combination immunotherapy Opdivo, Yervoy to treat skin cancer

June 17, 2016 Medical Communications, Research and Development, Sales and Marketing BMS, NICE, oncology, opdivo, regulation, skin cancer

The National Institute for Health and Care Excellence (Nice) has backed a combination of Bristol-Myers Squibb’s immunotherapy Opdivo (nivolumab) and …
News
roche_close

Roche gets a NICE knockback for melanoma drug, Cotellic

June 16, 2016 Medical Communications, Research and Development, Sales and Marketing Cotellic, NICE, Roche

The National Institute for Health and Care Excellence (NICE) has announced that that it has not recommended Roche’s melanoma drug, …
News
chemo-web

SMC recommends treatment for potentially fatal chemotherapy-related disease

June 16, 2016 Research and Development, Sales and Marketing Menarini, SMC, adneuric

The Scottish Medicines Consortium has recommended Adenuric (febuxostat), a treatment for a severe complication that can affect chemotherapy patients in …
News
alzheimers_web_credit_shutterstock

Chiasma cuts staff by 33% after FDA rejects rare disease drug, Mycapssa

June 16, 2016 Research and Development, Sales and Marketing FDA, chiasma, cutbacks, failure, workforce cuts

US-based biopharmaceutical company, Chiasma (NASDAQ: CHMA), has announced substantial job cuts as it attempts to restructure following the US Food …
News
roche

Roche secures EU approval for Gazyvaro in new lymphoma indication

June 16, 2016 Research and Development, Sales and Marketing EU, Gazyvaro, Roche, follicular lymphoma

Roche (SIX: RO) has announced that the European Commission has approved Gazyvaro (obinutuzumab), in combination with bendamustine chemotherapy, in patients …
News
The Gateway to Local Adoption Series

Latest content

Trio become latest Symbiosis commercial additions

October 12, 2026

UK immunoglobulin supply faces growing pressure, report warns

October 12, 2026

How will biomarker-led diagnostics reshape respiratory medicine?

October 11, 2026

Five Facts about COPD

October 11, 2026

“That gap between innovation and delivery was what stood out to me most”

October 11, 2026